赛马鲁肽
超重
2型糖尿病
肥胖
医学
糖尿病
内分泌学
利拉鲁肽
作者
Melanie J. Davies,Harpreet S. Bajaj,Christa Broholm,Astrid Eliasen,W. Timothy Garvey,Carel W. le Roux,Ildiko Lingvay,Christian Bøge Lyndgaard,Julio Rosenstock,Sue D. Pedersen
标识
DOI：10.1056/nejmoa2502082
摘要
Once-weekly cagrilintide-semaglutide (at a dose of 2.4 mg each) resulted in a significantly lower body weight than placebo in adults with obesity and type 2 diabetes. (Funded by Novo Nordisk; REDEFINE 2 ClinicalTrials.gov number, NCT05394519.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
无极微光
shhoing
Mic
Zx_1993
Jared
Harry
star
小青椒
嘴角微微仰起笑
小柚子的傻二哥
qingmoheng
pluto
昏睡的蟠桃
风中冰香
pcr163
Frank
bjbmtxy
茂茂
eric888
yznfly
殷勤的紫槐
彭于彦祖
GingerF
皖公网安备34019202002308
